Search results
Showing 91 to 105 of 118 results for osteoarthritis
Evidence-based recommendations on romosozumab (EVENITY) for severe osteoporosis in people after menopause who are at high risk of fracture.
Evidence-based recommendations on minimally invasive total hip replacement. This involves replacing the damaged hip joint (the top part of the upper leg bone and the socket in the hip bone that it fits into) with an artificial one.
View recommendations for IPG363Show all sections
Sections for IPG363
NICE has developed a Medtech Innovation Briefing (MIB) on the OSCAR 3 ultrasonic arthroplasty revision instrument for removing bone cement during prosthetic
Supporting the health and care system in improving productivity
Recovering core services and improving productivity is an immediate priority for the NHS. To help, we’ve put all our relevant guidance and recommendations supporting this work in one place.
Osteoarthritis: the care and management of osteoarthritis in adults (CG59)
This guidance has been updated and replaced by NICE guideline CG177.
LARS for reconstructing damaged intra-articular cruciate knee ligaments (MIB30)
NICE has developed a medtech innovation briefing (MIB) on LARS for reconstructing damaged intra-articular cruciate knee ligaments
Suture fixation of acute disruption of the distal tibiofibular syndesmosis (IPG521)
Evidence-based recommendations on suture fixation of acute disruption of the distal tibiofibular syndesmosis. This involves threading a suture through a tunnel made in the bones (tibia and fibula) and tying the ends together to fix the joint.
This medtech innovation briefing has been updated and replaced by NICE medical technologies guidance 76.
This guidance has been updated and replaced by NICE guideline NG226.
This quality standard covers assessing and managing obesity in adults, young people and children, including referral for specialist care and bariatric (weight loss) surgery. It includes people who are obese and have, or are at risk of, other medical conditions. It describes high-quality care in priority areas for improvement.
View quality statements for QS127Show all sections
Sections for QS127
- Quality statements
- Quality statement 1: Informing people of their BMI
- Quality statement 2: Discussion on the choice of interventions
- Quality statement 3: Referring children and young people for specialist care
- Quality statement 4: Referring adults with type 2 diabetes for bariatric surgery assessment
- Quality statement 5: Referring adults for bariatric surgery assessment
- Quality statement 6: Follow-up care after bariatric surgery
- Quality statement 7: Nutritional monitoring after discharge from the bariatric surgery service
Obesity in adults: prevention and lifestyle weight management programmes (QS111)
This quality standard covers preventing adults (aged 18 and over) from becoming overweight or obese. It includes strategies to increase physical activity and promote a healthy diet in the local population. It also covers lifestyle weight management programmes for adults who are overweight or obese. It describes high-quality care in priority areas for improvement.
View quality statements for QS111Show all sections
Sections for QS111
- Introduction
- List of quality statements
- Quality statement 1: Vending machines
- Quality statement 2: Nutritional information at the point of choosing food and drink options
- Quality statement 3: Prominent placement of healthy options
- Quality statement 4: Maintaining details of local lifestyle weight management programmes
- Quality statement 5: Publishing performance data on local lifestyle weight management programmes
- Quality statement 6: Raising awareness of lifestyle weight management programmes
Tanezumab for treating pain caused by bone metastases [ID3784]
Discontinued [GID-TA10922]
This guideline covers identifying, assessing and managing obesity in children (aged 2 years and over), young people and adults.
Platelet-rich plasma injections for osteoarthritis of the knee (IPG491)
This guidance has been updated and replaced by NICE interventional procedures guidance 637.
NICE has developed a medtech innovation briefing (MIB) on The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs .